durvalumab,pembrolizumab,ipilimumab,nivolumab
bms,astrazeneca,merck
['nivo', 'pacific', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'kn-799', 'lung', 'pembro', 'btcrc,lun16,081', 'lcsm,(-blcsm)']
#asco22 day 4: #lungcancer posters- locally advanced excellent discussion by dr j varlotto kn-799: pembro+concurrent crt btcrc lun16-081: consolidation nivo+ipi vs nivo alone x6 mos sprint: personalized io -rt-io improvements over pacific
#lcsm 
Associate Director Community Outreach- Thoracic Oncology-University of Miami @SylvesterCancer , Boricua en la Luna, Tweets are my own. (she/her)